ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2026

The cost-effectiveness of enzyme replacement therapies versus best supportive care for treating late onset Pompe disease in the UK NHS.

Matthew Walton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.